MIP-1095

• UNSPSC Description:

  MIP-1095 potently inhibits the glutamate carboxypeptidase activity of PSMA (Ki =0.24 nM)[1].

• Target Antigen:

  PSMA

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer; Others

• Assay Protocol:

  https://www.medchemexpress.com/mip-1095.html

• Smiles:

  O=C(O)CC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCCCNC(NC1=CC=C(I)C=C1)=O)=O

• Molecular Weight:

  564.33

• References & Citations:

  [1]Shawn M Hillier, et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res. 2009 Sep 1;69(17):6932-40.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  949575-22-8